牛唐2021-03-31 09:44
$灿菲特生物制药(CANF)$ 的药物Piclidenoson和Namodenoson在现有的六份分销协议中,剩余的潜在里程碑付款高达约1.3亿美元,外加两位数的净销售额分成。$新泰医药(MDGL)$ $泰格医药(SZ300347)$查看全文
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-03-12 AccNo: 0001213900-18-002836 Size: 744 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-03-12 AccNo: 0001213900-18-002836 Size: 744 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-03-12 AccNo: 0001213900-18-002834 Size: 400 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-03-12 AccNo: 0001213900-18-002834 Size: 400 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-03-12 AccNo: 0001213900-18-002836 Size: 744 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-03-12 AccNo: 0001213900-18-002834 Size: 400 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-03-09 AccNo: 0001213900-18-002753 Size: 27 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-03-06 AccNo: 0001213900-18-002602 Size: 33 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-02-28 AccNo: 0001213900-18-002364 Size: 37 KB 网页链接
$Can-Fite Biopharma Ltd Sponsored ADR (Israel)(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-02-22 AccNo: 0001213900-18-002184 Size: 40 KB 网页链接